書誌事項
- タイトル別名
-
- Cerebrospinal Stimulation and Low-dose Ketamine Drip Infusion Therapy for the Treatment of Neuropathic Pain
- 神経障害性疼痛の治療--脳脊髄刺激療法と低用量ケタミン点滴療法
- シンケイ ショウガイセイ トウツウ ノ チリョウ ノウ セキズイ シゲキ リョウホウ ト テイヨウリョウ ケタミン テンテキ リョウホウ
この論文をさがす
抄録
For the treatment of intractable neuropathic pain, drug challenge test is necessary and useful to examine the pharmacological background of the pain in each case. Based on the results of drug challenge test, we can select the candidates for low-dose ketamine drip infusion (LDKDI) therapy and cerebrospinal stimulation therapy. In cerebrospinal stimulation therapy, dual-lead spinal cord stimulation should be selected at first, since we can insert electrodes percutaneously and this is suitable for both the test stimulation and chronic implantation. For the treatment of peripheral deafferentation pain, which includes phantom limb pain and peripheral nerve injury pain, deep brain stimulation therapy of the thalamic relay nucleus is suitable. Motor cortex stimulation therapy is suitable for the treatment of central deafferentation pain, which includes post-stroke pain. LDKDI therapy combined with cerebrospinal stimulation therapy achieves remarkable pain reduction in the treatment of neuropathic pain.
収録刊行物
-
- 日大医学雑誌
-
日大医学雑誌 69 (3), 176-182, 2010
日本大学医学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282681408416384
-
- NII論文ID
- 10026989051
-
- NII書誌ID
- AN0018408X
-
- ISSN
- 18840779
- 00290424
-
- NDL書誌ID
- 10767655
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可